Taysha Gene Therapies, Inc. (TSHA): 10-Q filed Aug 11, 2026

Form type

10-Q

Filing date

Aug 11, 2026

Accession number

0001193125-26-344610

Filer

Taysha Gene Therapies, Inc. (CIK 1806310)